93 related articles for article (PubMed ID: 14595721)
1. Identification of two distinct subpopulations in a ganglioneuroblastoma: lack of co-localization of vasoactive intestinal polypeptide and calcitonin in ganglionic cells at the ultrastructural level.
Schellscheidt J; Baas S; Schmid KW; Vormoor J; Zimmer KP
Med Pediatr Oncol; 2003 Dec; 41(6):571-3. PubMed ID: 14595721
[No Abstract] [Full Text] [Related]
2. Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin.
Eskens FA; Roelofs EJ; Hermus AR; Verhagen CA
Anticancer Res; 1997; 17(6D):4667-70. PubMed ID: 9494586
[TBL] [Abstract][Full Text] [Related]
3. [Acute diarrhea as a leading symptom of ganglioneuroblastoma].
Schaarschmidt K; Morcate JJ; Schleef J; Saxena A; Willital GH
An Esp Pediatr; 1998 Nov; 49(5):519-22. PubMed ID: 9949599
[No Abstract] [Full Text] [Related]
4. Detection of vasoactive intestinal polypeptide messenger RNA in ganglioneuroblastoma by in situ hybridization.
Yoshioka M; Nagano I; Nakamura S; Imaizumi M; Kimura N
Endocr Pathol; 1990 Mar; 1(1):51. PubMed ID: 32357625
[TBL] [Abstract][Full Text] [Related]
5. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
6. [Vasoactive intestinal peptide-secreting ganglioneuroblastoma in a 20 month-old child].
González Toro MC; Pancho Flores C; López Iniesta S; Esquembre Menor C
An Pediatr (Barc); 2014 Mar; 80(3):e76-8. PubMed ID: 24290963
[No Abstract] [Full Text] [Related]
7. Evidence for molecular heterogeneity in human ganglioneuroblastoma.
Schmidt ML; Salwen HR; Chagnovich D; Bauer KD; Crawford SE; Cohn SL
Pediatr Pathol; 1993; 13(6):787-96. PubMed ID: 8108298
[TBL] [Abstract][Full Text] [Related]
8. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
[TBL] [Abstract][Full Text] [Related]
9. Presence and co-localization of vasoactive intestinal polypeptide with neuronal nitric oxide synthase in cells and nerve fibers within guinea pig intrinsic cardiac ganglia and cardiac tissue.
Parsons RL; Locknar SA; Young BA; Hoard JL; Hoover DB
Cell Tissue Res; 2006 Feb; 323(2):197-209. PubMed ID: 16220273
[TBL] [Abstract][Full Text] [Related]
10. A malignant cutaneous neuroendocrine tumor with features of Merkel cell carcinoma and differentiating neuroblastoma.
Vanchinathan V; Marinelli EC; Kartha RV; Uzieblo A; Ranchod M; Sundram UN
Am J Dermatopathol; 2009 Apr; 31(2):193-6. PubMed ID: 19318809
[TBL] [Abstract][Full Text] [Related]
11. Chronic watery diarrhea in a 22-month-old girl.
Rodriguez MM; Regalado JJ; Zaleski CG; Thomas C; Tamer AM
J Pediatr; 2000 Feb; 136(2):262-5. PubMed ID: 10657839
[No Abstract] [Full Text] [Related]
12. THE ULTRASTRUCTURE OF GANGLIONEUROBLASTOMA. OBSERVATIONS ON NEOPLASTIC GANGLION CELLS.
GONZALEZ-ANGULO A; REYES HA; REYNA AN
Neurology; 1965 Mar; 15():242-52. PubMed ID: 14262322
[No Abstract] [Full Text] [Related]
13. Sympathectomy-induced increases in calcitonin gene-related peptide (CGRP)-, substance P- and vasoactive intestinal peptide (VIP)-levels in parotid and submandibular glands of the rat.
Ekström J; Ekman R
Arch Oral Biol; 2005 Oct; 50(10):909-17. PubMed ID: 16137500
[TBL] [Abstract][Full Text] [Related]
14. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp.
Caviedes-Bucheli J; Lombana N; Azuero-Holguín MM; Munoz HR
Int Endod J; 2006 May; 39(5):394-400. PubMed ID: 16640639
[TBL] [Abstract][Full Text] [Related]
15. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
16. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of vasoactive intestinal peptide in periradicular lesions.
Azuero-Holguin MM; Leal-Fernandez MC; Restrepo-Mejia LM; Velandia-Daza G; Guzman-Quimbayo F; Urquiza-Martinez M
J Endod; 2003 Sep; 29(9):557-8. PubMed ID: 14503825
[No Abstract] [Full Text] [Related]
18. The secretin G-protein-coupled receptor family: teleost receptors.
Cardoso JC; Clark MS; Viera FA; Bridge PD; Gilles A; Power DM
J Mol Endocrinol; 2005 Jun; 34(3):753-65. PubMed ID: 15956345
[TBL] [Abstract][Full Text] [Related]
19. Structure of peripheral synapses: autonomic ganglia.
Gibbins IL; Morris JL
Cell Tissue Res; 2006 Nov; 326(2):205-20. PubMed ID: 16786367
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
